2022
DOI: 10.1007/978-3-030-81303-1_13-1
|View full text |Cite
|
Sign up to set email alerts
|

Serum Homocysteine as a Biomarker in Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…The dimeric form of cysteine is homocysteine, or it can form 'protein-bound' homocysteine with disulphide bonds. 2 Studies have associated mild-to-moderate elevations in homocysteine with diagnosed coronary disease, myocardial infarction, cerebrovascular disease, carotid intima-media thickness and arterial disease of the lower extremities. 3,4,5,6 Observational data concluded that each 5-μmol/L increase in total homocysteine levels conferred the same increase in risk for vascular disease as a 20-mg/dL increase in total cholesterol level.…”
mentioning
confidence: 99%
“…The dimeric form of cysteine is homocysteine, or it can form 'protein-bound' homocysteine with disulphide bonds. 2 Studies have associated mild-to-moderate elevations in homocysteine with diagnosed coronary disease, myocardial infarction, cerebrovascular disease, carotid intima-media thickness and arterial disease of the lower extremities. 3,4,5,6 Observational data concluded that each 5-μmol/L increase in total homocysteine levels conferred the same increase in risk for vascular disease as a 20-mg/dL increase in total cholesterol level.…”
mentioning
confidence: 99%